181:@0.890196:0.957873:0.914037:0.957873:0.914037:0.938882:0.890196:0.938882:0.007450:0.007801:0.008591
7:@0.941813:0.559752:0.963291:0.559752:0.963291:0.512274:0.941813:0.512274:0.021478
GENERAL DISCUSSION:@0.752908:0.064721:0.882355:0.064721:0.882355:0.047603:0.752908:0.047603:0.008404:0.006985:0.008759:0.006985:0.008423:0.007919:0.006294:0.002988:0.008423:0.003511:0.007807:0.008255:0.008367:0.007807:0.007807:0.003511:0.008442:0.008759
Final remarks:@0.147059:0.126494:0.295542:0.126494:0.295542:0.098384:0.147059:0.098384:0.010459:0.006217:0.013626:0.012318:0.009994:0.004648:0.013103:0.011069:0.017286:0.012318:0.013103:0.012199:0.012144
In this thesis I introduced and discussed several approaches that leverage state of the art :@0.147059:0.168344:0.886471:0.168344:0.886471:0.147971:0.147059:0.147971:0.006894:0.011756:0.004349:0.006620:0.011459:0.005615:0.007670:0.004349:0.006620:0.011299:0.009039:0.007601:0.005615:0.007670:0.004349:0.007259:0.004349:0.005615:0.011391:0.006437:0.007442:0.011276:0.011048:0.011345:0.008994:0.009106:0.011391:0.004360:0.009085:0.011596:0.011391:0.004349:0.011391:0.005615:0.007873:0.009108:0.011413:0.007533:0.007875:0.009108:0.011391:0.004349:0.007875:0.009336:0.009633:0.009039:0.007898:0.009405:0.005250:0.004349:0.008811:0.011048:0.011071:0.007442:0.011137:0.009291:0.008768:0.011299:0.009039:0.007670:0.004349:0.006620:0.011391:0.008811:0.006437:0.004349:0.005182:0.009336:0.009633:0.009039:0.007896:0.009201:0.009656:0.009039:0.004349:0.007510:0.006551:0.008811:0.006209:0.009039:0.004349:0.010843:0.006209:0.004349:0.006620:0.011299:0.009039:0.004349:0.009085:0.007967:0.006437:0.004109
genomic technology for the advancement of cancer research and diagnostics. I expect :@0.147059:0.188923:0.886462:0.188923:0.886462:0.168550:0.147059:0.168550:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.005912:0.006209:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.011048:0.010546:0.009724:0.005912:0.006026:0.010843:0.007807:0.005912:0.006620:0.011299:0.009039:0.005912:0.009291:0.011322:0.009838:0.009085:0.011596:0.008994:0.009039:0.017485:0.009039:0.011391:0.006437:0.005912:0.010843:0.006209:0.005912:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.005912:0.007442:0.009039:0.007875:0.009291:0.009085:0.007442:0.008765:0.011459:0.005912:0.009085:0.011598:0.011391:0.005912:0.011391:0.005796:0.009199:0.009861:0.011596:0.010957:0.007510:0.006437:0.005547:0.008994:0.007670:0.004497:0.005912:0.007259:0.005912:0.009108:0.010089:0.011505:0.009108:0.009106:0.006437:0.004109
that the assays and resources presented here will be of use to the international cancer ge-:@0.147059:0.209502:0.882353:0.209502:0.882353:0.189129:0.147059:0.189129:0.006620:0.011391:0.008811:0.006437:0.004018:0.006620:0.011299:0.009039:0.004018:0.009291:0.007533:0.007944:0.008925:0.009724:0.007670:0.004018:0.009085:0.011596:0.011391:0.004018:0.007442:0.009039:0.007875:0.010820:0.011413:0.007442:0.008994:0.009039:0.007670:0.004018:0.011071:0.007442:0.009039:0.007875:0.009039:0.011391:0.006209:0.009108:0.011391:0.004018:0.011299:0.009039:0.007442:0.009039:0.004018:0.014723:0.005752:0.005387:0.005250:0.004018:0.011251:0.009039:0.004018:0.010843:0.006209:0.004018:0.011413:0.007875:0.009039:0.004018:0.006209:0.011048:0.004018:0.006620:0.011299:0.009039:0.004018:0.005615:0.011391:0.006209:0.009039:0.007807:0.011687:0.008811:0.006437:0.005547:0.010843:0.011690:0.009402:0.005250:0.004018:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.004018:0.009656:0.008994:0.007533
nomics and cancer research community. Our OC PDO biobank serves the OC research :@0.147059:0.230080:0.886510:0.230080:0.886510:0.209707:0.147059:0.209707:0.011596:0.010843:0.017645:0.005547:0.008994:0.007670:0.004223:0.009085:0.011598:0.011391:0.004223:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.004223:0.007442:0.009039:0.007875:0.009291:0.009085:0.007442:0.008765:0.011459:0.004223:0.008994:0.010843:0.017645:0.017280:0.011413:0.011756:0.005273:0.006437:0.007989:0.004497:0.004223:0.016501:0.011413:0.007807:0.004223:0.016778:0.014678:0.004223:0.011664:0.016504:0.016412:0.004223:0.010820:0.005547:0.010957:0.011117:0.009085:0.011870:0.010523:0.004223:0.007875:0.009039:0.008400:0.009633:0.009039:0.007670:0.004223:0.006620:0.011299:0.009039:0.004223:0.016778:0.014678:0.004223:0.007442:0.009039:0.007875:0.009291:0.009085:0.007442:0.008765:0.011459:0.004109
community and shows potential to also impact the OC clinical care. Continued estab-:@0.147059:0.250659:0.882353:0.250659:0.882353:0.230286:0.147059:0.230286:0.008994:0.010843:0.017645:0.017280:0.011413:0.011756:0.005273:0.006437:0.009724:0.005387:0.009085:0.011596:0.011391:0.005387:0.007558:0.011299:0.010866:0.014723:0.007670:0.005387:0.011505:0.010820:0.006209:0.009039:0.011391:0.006437:0.005798:0.009405:0.005250:0.005387:0.006209:0.011048:0.005387:0.009405:0.005250:0.007875:0.011048:0.005387:0.005615:0.017280:0.011368:0.009291:0.009106:0.006437:0.005387:0.006620:0.011299:0.009039:0.005387:0.016778:0.014678:0.005387:0.008763:0.005250:0.005615:0.011756:0.005547:0.009108:0.009405:0.005250:0.005387:0.009108:0.009085:0.007442:0.008743:0.004497:0.005387:0.014995:0.010843:0.011393:0.006437:0.005615:0.011393:0.011345:0.009106:0.011391:0.005387:0.009039:0.007510:0.006551:0.009108:0.011071:0.007533
lishment and expansion of PDOs will help reach this potential, as discussed above. Fur-:@0.147059:0.271238:0.882353:0.271238:0.882353:0.250865:0.147059:0.250865:0.005250:0.005615:0.007556:0.011459:0.017485:0.009039:0.011391:0.006437:0.004497:0.009085:0.011596:0.011391:0.004485:0.009108:0.010089:0.011368:0.009085:0.011619:0.007601:0.005547:0.010843:0.011756:0.004497:0.010843:0.006209:0.004485:0.011664:0.016504:0.016253:0.007670:0.004485:0.014723:0.005752:0.005387:0.005250:0.004485:0.011302:0.008946:0.004908:0.011276:0.004497:0.007442:0.009291:0.009291:0.008765:0.011459:0.004485:0.006620:0.011459:0.005615:0.007670:0.004485:0.011505:0.010820:0.006209:0.009039:0.011391:0.006437:0.005798:0.009405:0.004976:0.004497:0.004485:0.009291:0.007670:0.004485:0.011391:0.005615:0.007875:0.009108:0.011413:0.007533:0.007873:0.009108:0.011391:0.004497:0.009108:0.011251:0.010866:0.009635:0.008743:0.004497:0.004485:0.010729:0.011413:0.007202:0.007533
thermore, I leverage SVs, which have been traditionally overlooked in cancer genomics, :@0.147059:0.291816:0.886462:0.291816:0.886462:0.271444:0.147059:0.271444:0.006620:0.011299:0.009039:0.007807:0.017485:0.010843:0.007442:0.008743:0.004497:0.004314:0.007259:0.004314:0.005182:0.009336:0.009633:0.009039:0.007898:0.009199:0.009656:0.009039:0.004314:0.010112:0.015089:0.007670:0.004497:0.004314:0.014792:0.011459:0.005545:0.008765:0.011459:0.004314:0.011393:0.008925:0.009633:0.009039:0.004314:0.011251:0.009108:0.009039:0.011756:0.004314:0.006437:0.007898:0.009291:0.011391:0.005273:0.006437:0.005547:0.010843:0.011687:0.009405:0.005387:0.005182:0.009724:0.004314:0.010866:0.009633:0.009039:0.007601:0.005182:0.011276:0.010934:0.010272:0.009108:0.011391:0.004314:0.005615:0.011756:0.004314:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.004314:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.007670:0.004497:0.004109
and long read sequencing technologies and provide community resources and personal-:@0.147059:0.312395:0.882353:0.312395:0.882353:0.292022:0.147059:0.292022:0.009085:0.011596:0.011391:0.003732:0.005182:0.010843:0.011459:0.009861:0.003732:0.007442:0.009291:0.009291:0.011391:0.003732:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.003732:0.006209:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.011048:0.009861:0.005547:0.009039:0.007670:0.003732:0.009085:0.011596:0.011391:0.003732:0.011071:0.007442:0.010866:0.009838:0.005547:0.011322:0.009039:0.003732:0.008994:0.010843:0.017645:0.017280:0.011413:0.011756:0.005273:0.006437:0.009724:0.003732:0.007442:0.009039:0.007875:0.010820:0.011413:0.007442:0.008994:0.009039:0.007670:0.003732:0.009085:0.011596:0.011391:0.003732:0.011505:0.009039:0.007624:0.007875:0.010843:0.011687:0.009405:0.005248:0.007533
ized medicine approaches that use somatic SVs, overcoming previous technological lim-:@0.147059:0.332974:0.882353:0.332974:0.882353:0.312601:0.147059:0.312601:0.005615:0.008834:0.009108:0.011391:0.003698:0.017485:0.009108:0.011391:0.005547:0.008994:0.005615:0.011596:0.009039:0.003698:0.008811:0.011048:0.011071:0.007442:0.011137:0.009291:0.008768:0.011299:0.009039:0.007670:0.003698:0.006620:0.011391:0.008811:0.006437:0.003698:0.011413:0.007875:0.009039:0.003698:0.007875:0.010843:0.017577:0.008811:0.006437:0.005547:0.008994:0.003698:0.010112:0.015089:0.007670:0.004497:0.003698:0.010866:0.009633:0.009039:0.007442:0.008994:0.010843:0.017645:0.005615:0.011459:0.009861:0.003698:0.011071:0.007442:0.009336:0.009838:0.005547:0.010820:0.011413:0.007670:0.003698:0.006209:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.011048:0.009861:0.005547:0.009108:0.009405:0.005250:0.003698:0.005250:0.005615:0.017574:0.007533
itations. With the speed that genomic technology advances, maybe these approaches will :@0.147059:0.353553:0.886553:0.353553:0.886553:0.333180:0.147059:0.333180:0.005273:0.006551:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.004497:0.003584:0.019951:0.005273:0.006620:0.011459:0.003584:0.006620:0.011299:0.009039:0.003584:0.007510:0.011505:0.009106:0.009108:0.011391:0.003584:0.006620:0.011391:0.008811:0.006437:0.003584:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.003584:0.006209:0.009108:0.008765:0.011459:0.011596:0.010934:0.005184:0.011048:0.010544:0.009724:0.003584:0.009291:0.011322:0.009838:0.009085:0.011596:0.008994:0.009039:0.007670:0.004497:0.003584:0.017577:0.008925:0.009998:0.011254:0.009039:0.003584:0.006620:0.011299:0.009039:0.007875:0.009039:0.003584:0.008811:0.011048:0.011071:0.007442:0.011139:0.009291:0.008765:0.011299:0.009039:0.007670:0.003584:0.014723:0.005752:0.005387:0.005250:0.004109
become outdated in the next few years with new technologies, methods and algorithms. :@0.147059:0.374131:0.886439:0.374131:0.886439:0.353758:0.147059:0.353758:0.011254:0.009108:0.008994:0.010843:0.017485:0.009039:0.004246:0.010820:0.011071:0.006209:0.011573:0.008811:0.006209:0.009108:0.011391:0.004246:0.005615:0.011756:0.004246:0.006620:0.011299:0.009039:0.004246:0.011596:0.009108:0.010089:0.006437:0.004246:0.006026:0.009336:0.014723:0.004246:0.009519:0.009288:0.009087:0.007624:0.007670:0.004246:0.014723:0.005271:0.006620:0.011459:0.004246:0.011596:0.009336:0.014723:0.004246:0.006209:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.011048:0.009861:0.005547:0.009039:0.007670:0.004497:0.004246:0.017485:0.009131:0.006620:0.011299:0.011276:0.011391:0.007670:0.004246:0.009085:0.011596:0.011391:0.004246:0.009405:0.005250:0.009653:0.010845:0.007807:0.005273:0.006620:0.011459:0.017508:0.007670:0.004497:0.004109
Nevertheless, the contributions presented here are relevant to drive this technological :@0.147059:0.394710:0.886532:0.394710:0.886532:0.374337:0.147059:0.374337:0.015522:0.009336:0.009633:0.009039:0.007967:0.006620:0.011299:0.008948:0.005182:0.009039:0.007533:0.007670:0.004497:0.006300:0.006620:0.011299:0.009039:0.006300:0.008994:0.010843:0.011391:0.006437:0.007807:0.005547:0.010797:0.011071:0.006437:0.005547:0.010843:0.011619:0.007670:0.006300:0.011071:0.007442:0.009039:0.007875:0.009039:0.011391:0.006209:0.009108:0.011391:0.006300:0.011299:0.009039:0.007442:0.009039:0.006300:0.009085:0.007442:0.009039:0.006300:0.007442:0.008948:0.005182:0.009336:0.009838:0.009085:0.011391:0.006437:0.006300:0.006209:0.011048:0.006300:0.011391:0.007807:0.005547:0.009633:0.009039:0.006300:0.006620:0.011459:0.005615:0.007670:0.006300:0.006209:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.011048:0.009861:0.005547:0.009108:0.009405:0.005250:0.004109
advance by pushing the limits of the state of the art of cancer genomics.:@0.147059:0.415289:0.741258:0.415289:0.741258:0.394916:0.147059:0.394916:0.009291:0.011322:0.009838:0.009085:0.011596:0.008994:0.009039:0.004109:0.010843:0.009724:0.004109:0.011048:0.011413:0.007556:0.011459:0.005615:0.011459:0.009861:0.004109:0.006620:0.011299:0.009039:0.004109:0.005250:0.005615:0.017645:0.005271:0.006437:0.007670:0.004109:0.010843:0.006209:0.004109:0.006620:0.011299:0.009039:0.004109:0.007510:0.006551:0.008811:0.006209:0.009039:0.004109:0.010843:0.006209:0.004109:0.006620:0.011299:0.009039:0.004109:0.009085:0.007967:0.006437:0.004109:0.010843:0.006209:0.004109:0.009106:0.009085:0.011598:0.008994:0.009039:0.007807:0.004109:0.009653:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.007670:0.004497